Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03181828 · ClinicalTrials.gov registry record · Phase 1
Manipulating the Gut Microbiome Study
A Phase 1 study, sponsored by Nicholas Ah Mew.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT03181828 is a Phase 1 study that was terminated before completion, run by Nicholas Ah Mew. The registered enrollment target is 4 participants.
The verdict
NCT03181828, a Phase 1 study, was terminated before completion, sponsored by Nicholas Ah Mew.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders
Interventions
- OTHER No treatment
- DRUG Acetohydroxamic Acid Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-03-24 |
| Est. Completion | 2018-06-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03181828
The ClinicalTrials.gov registry entry for NCT03181828 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nicholas Ah Mew, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which No treatment is the first listed.
NCT03181828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03181828 about?
NCT03181828 is a clinical study titled "Manipulating the Gut Microbiome Study". The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders
What is the current status of trial NCT03181828?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2017-03-24. Estimated completion is 2018-06-05.
What interventions are being tested in trial NCT03181828?
The interventions under investigation include: No treatment (OTHER), Acetohydroxamic Acid Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT03181828?
This trial is sponsored by Nicholas Ah Mew, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.